LCC [Liverpool ChiroChem]

Our CEO, Paul Colbon, and CSO, Gary Tilbrook, will be attending Bio-Europe, happening on the 4-6th November, 2024, in Stockholm, Sweden. Paul and Gary would be happy to meet during the conference. They are looking forward to engaging with the small molecule drug discovery community, so please get in touch if you would like to have a chat! 👋 #BioEurope #DrugDiscovery

The team are back after a fantastic two days at the SCI® Where Science Meets Business / Royal Society of Chemistry Targeting Protein Degradation 4 meeting, hosted at Cranfield University. A big thank you to all of the speakers who delivered such insightful talks and to the organising committee, who planned such a wonderful event. It was great being able to catch up with some familiar faces, as well as making new connections. Finally, thank you to everyone who came over to our poster, we thoroughly enjoyed discussing the project with you! #PROTACs #MolecularGlues #Networking

Our Business Development Team Tami Warnock and Leah Green are excited to attend the 'Targeting Protein Degradation 4' conference happening next week on the 15th-16th October, at Cranfield University. The team will be displaying a poster titled 'VHL PROTACs Targeting β-catenin' which explores LCC's collaboration with the University of Turin. The project exploited in silico PROTACs design based on LCC's novel semi flexible linkers, physchem predictions and TC modelling to rationally design and synthesise chameleonic PROTACs targeting β-catenin. If you're attending the conference, come and say hello to the team and pop over to the poster to learn about the project in more detail! 👋 #PROTACs #DrugDiscovery

👏 Congratulations to our portfolio company LCC [Liverpool ChiroChem] on forming a strategic partnership with Veritas In Silico Inc. (VIS) 👏 🧬 The agreement will see both companies working together on mRNA-targeted drug discovery and development, with LCC's chemistry platform working in tandem with VIS's unique biology platform (ibVIS®). 💬 Check out the full press release via the link to see what Paul Colbon (CEO and co-founder of LCC [Liverpool ChiroChem]) and Dr Shingo Nakamura, PhD, MBA (Representative Director and CEO of VIS) had to say. 🗞️ https://lnkd.in/eVd7xipv

The LCC [Liverpool ChiroChem] team at BioJapan / JTB Communication Design Paul Colbon

A very special day for LCC [Liverpool ChiroChem] and Veritas In Silico Inc.

LCC [Liverpool ChiroChem] are proud to announce that we are entering into a strategic collaboration with Veritas In Silico Inc. (VIS) 🤝 , which combines LCC’s chemistry platform and VIS’ unique biology platform 'ibVIS®’. The partnership aims to accelerate drug discovery and development by generating first-in-class and best-in-class assets of small molecules against undisclosed mRNA targets. For more details, read the full press release here 👇 English: https://lnkd.in/gziZQK7q Japanese: https://lnkd.in/gtqAQYjs To learn more about VIS or LCC, please visit our websites: VIS website: https://lnkd.in/eX64Qmvn LCC website: https://lnkd.in/e_jz8CqB #Collaboration #DrugDiscovery #PressRelease

We are delighted to announce the appointment of Tim R. Kendall (ティム　ケンダル) as a Non-Executive Director (NED). 👏 🎉 LCC [Liverpool ChiroChem] have been working with Tim and ConneKTia for the past 2 years, as LCC has forged strategic relationships with Japanese biotech and pharma companies. During this time, Tim has formed a trusted relationship with the company and has really become ‘one of the team’ at LCC! We're looking forward to seeing LCC's relationships with Japanese biotech and pharma companies continue to grow as Paul Colbon has just arrived in Japan for BioJapan / JTB Communication Design, where he'll continue to be supported by Tim.

I'll be in Yokohama next week exhibiting at BioJapan / JTB Communication Design, supported by ConneKTia (Tim R. Kendall (ティム　ケンダル) and Kayo Kendall). If you're at the event, please come and say hello at booth B-60. Arigato.

Some of the LCC team are looking forward to attending the ELRIG UK Drug Discovery 2024 again this year in London, which as usual, looks to have a programme filled with exciting talks, posters, and more! Bethany Trueman, Tami Warnock, and Thomas Welsh will be there and available for a chat in the networking breaks 👋 See you there! 😃 #ELRIG24 #DrugDiscovery